Caribbean territories reporting indigenous cases of Chikungunya fever now number six and confirmed and suspected cases number at least 786, with several more imported cases as well, according to a Jan 24 report from the Pan American Health Organization (PAHO).
That number is up from 485 in the previous update, from the European Centre for Disease Prevention and Control, on Jan 20.
The number of confirmed or probable cases of chikungunya—a mosquito-borne disease that, aside from imported cases, had not been seen in the Caribbean until just last month—on St. Martin and nearby islands has spiked to 485, the European Centre for Disease Prevention and Control (ECDC) said in an update yesterday.
Rotavirus vaccination in infants slightly raises the risk of a specific intestinal disorder, researchers reported today in The New England Journal of Medicine.
The victim of the first human H5N1 infection reported in the Americas was a woman in her 20s from Red Deer, Alta., who was a nurse at a hospital there, according to reports in the local newspaper, the Red Deer Advocate.
The French side of the Caribbean island of St. Martin now has 89 confirmed and 20 probable cases of chikungunya, the European Centre for Disease Prevention and Control (ECDC) said in a Jan 4 update.
Cases have grown to 66 on the French side of St. Martin, which may elevate the US risk.
A meeting of world experts last week concluded that convalescent serum—antibody-rich blood from survivors—may be a promising tool for treating Middle East respiratory syndrome coronavirus (MERS-CoV) infections.
The US Centers for Disease Control and Prevention (CDC) has issued a travel health notice because of recent cases of chikungunya on the Caribbean island of St. Martin, the agency said today in a news release.
The American Academy of Pediatrics (AAP) today recommended that all infants, children, and pregnant women avoid raw (unpasteurized) milk, and called for a nationwide ban on the sale of all raw-milk products.
Narrow-spectrum antibiotics were associated with a 10-hour shorter hospital stay compared with broad-spectrum therapy for community-acquired pneumonia (CAP) in children—an 18% drop—according to a multicenter retrospective cohort study yesterday in Pediatrics.
